According to the modern definition of biocompatibility, a biocompatibl
e material need not be inert but be bioactive. A benign reactivity imp
lies that the reactivity has to be appropriate for the intended use. C
hitosan, a non-acetylated or partially deacetylated chitin (a linear h
omopolymer of beta(1-4)-linked N-acetylglucosamine) has been proposed
as a biomaterial because of its apparent satisfactory biocompatibility
, The present investigation demonstrates that chitosan has an in vitro
stimulatory effect on both macrophage nitric oxide (NO) production an
d chemotaxis. The macrophage NO secretion is attributed to the N-acety
lglucosamine unit of the chitosan molecule rather than to the glucosam
ine residue (28 and 15 mu M NO respectively). Moreover, the immune sti
mulatory effect of chitosan was very specific since other glycosaminog
lycans, such as N-acetyl-D-mannosamine and N-acetyl-D-galactosamine, h
ad no effects on NO production (5 and 8 respectively). In vivo experim
ents strengthen this hypothesis. Transmission electron microscopy anal
ysis identifies the presence of many leucocytes in the specimens after
14 d post-implantation, showing poor healing processes (i.e, fibrobla
st proliferation and collagen deposition) that characterize the tissue
repair at this time in our animal model.